Related references
Note: Only part of the references are listed.International Interlaboratory Proficiency Testing Program for Measurement of Azole Antifungal Plasma Concentrations
Roger J. M. Bruggemann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Hallucinations during voriconazole therapy
Dimitrios I. Zonios et al.
CLINICAL INFECTIOUS DISEASES (2008)
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes
Andres Pascual et al.
CLINICAL INFECTIOUS DISEASES (2008)
What is the Therapeutic Range for voriconazole?
Russell E. Lewis
CLINICAL INFECTIOUS DISEASES (2008)
Impact of intravenous administration of voriconazole in critically ill patients with impaired renal function
F. Alvarez-Lerma et al.
JOURNAL OF CHEMOTHERAPY (2008)
Invasive aspergillosis following hematopoietic cell transplantation: Outcomes and prognostic factors associated with mortality
Arlo Upton et al.
CLINICAL INFECTIOUS DISEASES (2007)
Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy
S. M. Trifilio et al.
BONE MARROW TRANSPLANTATION (2007)
Voriconazole therapeutic drug monitoring
J Smith et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities
K Tan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Safety of voriconazole in a patient with CYP2C9*2/CYP2C9*2 genotype
Marcus J. P. Geist et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients
S Trifilio et al.
BONE MARROW TRANSPLANTATION (2005)
Pharmacokinetic interaction between voriconazole and ciclosporin A following allogeneic bone marrow transplantation
AH Groll et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole
R Hyland et al.
DRUG METABOLISM AND DISPOSITION (2003)
Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens
L Purkins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients
AJ Romero et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: A dose escalation study
HM Lazarus et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
DW Denning et al.
CLINICAL INFECTIOUS DISEASES (2002)
Aspergillosis case - Fatality rate: Systematic review of the literature
SJ Lin et al.
CLINICAL INFECTIOUS DISEASES (2001)
Share Paper
